Achieve Life Sciences Inc...

NASDAQ: ACHV · Real-Time Price · USD
2.54
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
2.46
-3.34%
After-hours: Aug 15, 2025, 07:49 PM EDT

Achieve Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-39.83M -29.82M -42.35M -33.15M
Depreciation & Amortization
229K 228K 236K 250K
Stock-Based Compensation
5.33M 3.44M 3.27M 2.19M
Other Working Capital
969K 264K -720K 725K
Other Non-Cash Items
2.09M 2.45M 1.2M 41K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.41M -778K 99K 1.23M
Operating Cash Flow
-29.77M -24.48M -37.55M -29.44M
Capital Expenditures
n/a -21K n/a -17K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-47.89M n/a n/a n/a
Sales Maturities Of Investments
26.31M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-21.58M -21K n/a -17K
Debt Repayment
-8.29M n/a n/a 14.93M
Common Stock Repurchased
n/a -30K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-114K 7K 103K 338K
Financial Cash Flow
48.53M 15.28M 19.3M 36.61M
Net Cash Flow
-2.82M -9.22M -18.25M 7.17M
Free Cash Flow
-29.77M -24.5M -37.55M -29.46M